National Health Investors (NHI) Stock Price, News & Analysis

Company Overview

National Health Investors, Inc. (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development. The company evaluates opportunities across multiple sub-sectors of the healthcare real estate market, favoring markets with strong demographic trends and limited new supply. NHI’s portfolio spans more than two dozen states, with a concentration in key Sun Belt and Midwest regions, and reflects longstanding partnerships with established industry operators known for high standards of clinical outcomes and facility management.

Headquartered in Orlando, Florida, National Health Investors is overseen by an experienced management team with deep expertise in real estate finance, healthcare operations, and capital markets. The company has maintained an investment-grade credit rating, supporting its access to diverse capital sources for funding acquisitions and refinancings. Through its patient-capital approach and focus on essential healthcare properties, NHI strives to deliver stable, risk-adjusted returns for its shareholders while enabling the growth and sustainability of critical care providers nationwide.

Key Stats

• Today's Range: $71.00 to $72.74
• 50-Day Range: $69.85 to $80.99
• 52-Week Range: $67.94 to $91.38
• Volume: 336,173 shs
• Average Volume: 330,703 shs
• Market Capitalization: $3.55 billion
• P/E Ratio: 20.89
• Dividend Yield: 5.20%
• Price Target: $83.71
• Consensus Rating: Moderate Buy

National Health Investors Stock Analysis - MarketRank™

National Health Investors scored higher than 90% of companies evaluated by MarketBeat, and ranked 15th out of 189 stocks in the real estate sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

National Health Investors has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 5 buy ratings, 2 hold ratings, and 1 sell rating.

Upside Potential

National Health Investors has a consensus price target of $83.71, representing about 15.8% upside from its current price of $72.27.

Amount of Analyst Coverage

National Health Investors has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 5.23%

Earnings Growth

Earnings for National Health Investors are expected to grow by 5.23% in the coming year, from $4.78 to $5.03 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of National Health Investors is 20.89, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.11.

Price to Earnings Ratio vs. Sector

The P/E ratio of National Health Investors is 20.89, which means that it is trading at a less expensive P/E ratio than the Real Estate sector average P/E ratio of about 28.39.

Price to Earnings Growth Ratio

National Health Investors has a PEG Ratio of 3.78. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

National Health Investors has a P/B Ratio of 2.25. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

4.55% of the float of National Health Investors has been sold short.

Short Interest Ratio / Days to Cover

National Health Investors has a short interest ratio ("days to cover") of 5.64.

Change versus previous month

Short interest in National Health Investors has recently increased by 45.27%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Leadership

National Health Investors is a leading dividend payer. It pays a dividend yield of 5.11%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

National Health Investors does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of National Health Investors is 108.67%. Payout ratios above 75% are not desirable because they may not be sustainable.

Dividend Sustainability

Based on earnings estimates, National Health Investors will have a dividend payout ratio of 74.75% next year. This indicates that National Health Investors will be able to sustain or increase its dividend.

News and Social Media

• Score: 3.9 / 5
• News Sentiment: 1.27

News Sentiment

National Health Investors has a news sentiment score of 1.27. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.93 average news sentiment score of Real Estate companies.

News Coverage This Week

MarketBeat has tracked 8 news articles for National Health Investors this week, compared to 3 articles on an average week.

Search Interest

5 people have searched for NHI on MarketBeat in the last 30 days. This is an increase of 150% compared to the previous 30 days.

MarketBeat Follows

Only 1 people have added National Health Investors to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 3.7 / 5
• Insider Trading: Acquiring Shares

Cluster Insider Buying

2 insiders have purchased shares of National Health Investors in the last three months. Multiple insiders buying is a strong bullish signal.

Net Insider Buying

Over the last three months, insiders have purchased a net $167,028.00 in company stock, which represents 0.0047% of the company's market cap.

Insider Buying vs. Insider Selling

In the past three months, National Health Investors insiders have bought more of their company's stock than they have sold. Specifically, they have bought $167,028.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

2.70% of the stock of National Health Investors is held by insiders.

Percentage Held by Institutions

62.51% of the stock of National Health Investors is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Record date for 8/7 Dividend: 6/30/2026
• Ex-Dividend for 8/7 Dividend: 6/30/2026
• Dividend Payable: 8/07/2026
• Last Earnings: 8/10/2026
• Today: 9/02/2026
• Next Earnings (Estimated): 11/05/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Real Estate
• Industry: Healthcare REITs
• Sub-Industry: Healthcare REITs
• Current Symbol: NYSE:NHI
• CIK: 877860
• Web: www.nhireit.com
• Phone: (615) 890-9100
• Fax: 615-225-3030
• Employees: 20
• Year Founded: 1991

Price Target and Rating

• Average Price Target for National Health Investors: $83.71
• High Price Target: $94.00
• Low Price Target: $78.00
• Potential Upside/Downside: +15.8%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 8 Analysts

Profitability

• EPS (Trailing Twelve Months): $3.46
• Trailing P/E Ratio: 20.89
• Forward P/E Ratio: 15.12
• P/E Growth: 3.78
• Net Income: $142.18 million
• Net Margins: 38.56%
• Pretax Margin: 38.80%
• Return on Equity: 10.89%
• Return on Assets: 5.88%

Debt

• Debt-to-Equity Ratio: 0.81
• Current Ratio: 6.78
• Quick Ratio: 6.78

Sales & Book Value

• Annual Sales: $432.12 million
• Price / Sales: 8.21
• Cash Flow: $4.87 per share
• Price / Cash Flow: 14.84
• Book Value: $32.15 per share
• Price / Book: 2.25

Miscellaneous

• Outstanding Shares: 49,110,000
• Free Float: 47,784,000
• Market Cap: $3.55 billion
• Optionable: Optionable
• Beta: 0.51